SCHEMBL9953971

SCHEMBL9953971

O=C(Nc1nc2ccc(Br)cc2c(=O)[nH]1)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ MEN1 O00255 3/20 0.65
▸ KMT2A Q03164 3/20 0.65
▸ POLB P06746 1/20 0.65
▸ TSHR P16473 1/20 0.65
▸ RAB9A P51151 5/20 0.57
▸ NPC1 O15118 3/20 0.57
▸ MAPT P10636 4/20 0.57
▸ LMNA P02545 3/20 0.57
▸ ADORA2A P29274 2/20 0.56
▸ PKM P14618 1/20 0.56
▸ MAOB P27338 1/20 0.56
▸ MMP2 P08253 1/20 0.52
▸ MMP9 P14780 1/20 0.52
▸ MMP8 P22894 1/20 0.52
▸ MMP13 P45452 1/20 0.52
▸ ESR1 P03372 1/20 0.52
▸ SCD O00767 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ TUBB4A P04350 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31329348 0.84 NPC1 (0.70) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL31317513 0.77 TOP2A (0.54) SMN1; SMN2MEN1KMT2APOLBRAB9A
SCHEMBL31329341 0.75 NPC1 (0.81) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL31329343 0.73 NPC1 (0.78) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL31329354 0.73 NPC1 (1.00) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL1031135 0.72 LMNA (0.48) SMN1; SMN2MEN1KMT2APOLBTSHR
SCHEMBL13343587 0.72 RXFP1 (0.56) SMN1; SMN2MEN1KMT2ANPC1MAPT
SCHEMBL3926899 0.72 NPC1 (1.00) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL31329345 0.72 NPC1 (0.74) SMN1; SMN2MEN1KMT2ARAB9ANPC1
SCHEMBL3115005 0.71 TYMS (0.72) SMN1; SMN2POLBRAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 — — WO disclosed
Send feedback